|
|
 | | | |
- close
- close
- close
- close
This excerpt taken from the SYT 20-F filed Mar 1, 2006. Plant Science Syngenta’s Plant Science reportable segment is an incubator of several development stage activities which may meet the criteria to be reported as separate segments in the future. These activities include development of animal feed products, F-24 technology based on research into enzymes, and traits with the potential to enhance the agronomic, nutritional or pharmaceutical properties of plants. Syngenta has not generated material revenues from these activities to date. The route to market for certain of these technologies is not yet clear. Syngenta has judged it appropriate to aggregate the financial information relating to these activities into a single reportable segment. This excerpt taken from the SYT 6-K filed Feb 14, 2006. Plant Science: In enzymes, sales of QUANTUM™ were made in Mexico, with registration pending in the USA. Amylase for corn
bioethanol is undergoing pilot trials and US registration dossiers have been submitted. Work on plant-produced pharmaceutical compounds progressed in 2005 to the stage of clinical trials; however, in view of the extended time lines and associated
costs of full commercialization it has been decided to seek third parties to take these projects through development to commercial launch. Resources released in R&D will be redirected to other businesses.
This excerpt taken from the SYT 20-F filed Mar 16, 2005. Plant Science Syngenta’s Plant Science reportable segment is an incubator of several development stage activities which may meet the criteria to be reported as separate segments in the future. These activities include development of animal feed products, technology based on research into enzymes, and traits with the potential to enhance the agronomic, nutritional or pharmaceutical properties of plants. Syngenta has not generated material revenues from these activities to date. The route to market for certain of these technologies is not yet clear. Syngenta has judged it appropriate to aggregate the financial information relating to these activities into a single reportable segment. This excerpt taken from the SYT 6-K filed Feb 15, 2005. Plant Science: Following the acquisition of Garst and Golden Harvest, the management of corn and soybean trait development activities with the associated cost has been
transferred to Seeds. In August Syngenta signed a long-term technology agreement with Delta and PineLand (D&PL), the US leader in cotton seed, under which D&PL will commercialize Syngenta’s insect control technology for
cotton.
Restructuring, impairment and Discontinued Operations: Total restructuring and impairment charges during the period were $354 million (cash: $171 million; non-cash: $183 million) of which the majority related to the program to streamline global operations, announced in February 2004. The total cost of the program is expected to be around $850 million over five years including a non-cash charge of $350 million. Peak savings of $300 million are expected by the end of 2008. The sale of SF Chem resulted in an additional charge of $108m.
| EXCERPTS ON THIS PAGE:
|
| |||||||
